Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 Update
Börje Ljungberg, Laurence Albigès, Yasmin Abu‐Ghanem, et al.
European Urology (2019) Vol. 75, Iss. 5, pp. 799-810
Open Access | Times Cited: 1199

Showing 1-25 of 1199 citing articles:

Renal Mass and Localized Renal Cancer: Evaluation, Management, and Follow-Up: AUA Guideline: Part I
Steven C. Campbell, Peter E. Clark, Sam S. Chang, et al.
The Journal of Urology (2021) Vol. 206, Iss. 2, pp. 199-208
Open Access | Times Cited: 467
Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Immune Checkpoint Inhibition Is the New Backbone in First-line Treatment of Metastatic Clear-cell Renal Cell Carcinoma
Laurence Albigès, Tom Powles, Michael Staehler, et al.
European Urology (2019) Vol. 76, Iss. 2, pp. 151-156
Open Access | Times Cited: 195
Management of Metastatic Clear Cell Renal Cell Carcinoma: ASCO Guideline
W. Kimryn Rathmell, R. Bryan Rumble, Peter J. Van Veldhuizen, et al.
Journal of Clinical Oncology (2022) Vol. 40, Iss. 25, pp. 2957-2995
Open Access | Times Cited: 194
MYB oncoproteins: emerging players and potential therapeutic targets in human cancer
Ylenia Cicirò, Arturo Sala
Oncogenesis (2021) Vol. 10, Iss. 2
Open Access | Times Cited: 134
Stereotactic Radiotherapy and Short-course Pembrolizumab for Oligometastatic Renal Cell Carcinoma—The RAPPORT Trial
Shankar Siva, Mathias Bressel, Simon Wood, et al.
European Urology (2021) Vol. 81, Iss. 4, pp. 364-372
Closed Access | Times Cited: 107
Sunitinib Alone or After Nephrectomy for Patients with Metastatic Renal Cell Carcinoma: Is There Still a Role for Cytoreductive Nephrectomy?
Arnaud Méjean, Alain Ravaud, Simon Thézenas, et al.
European Urology (2021) Vol. 80, Iss. 4, pp. 417-424
Open Access | Times Cited: 106
miRNAs as potential game-changers in renal cell carcinoma: Future clinical and medicinal uses
Mohammed S. Elballal, Al-Aliaa M. Sallam, Ahmed E. Elesawy, et al.
Pathology - Research and Practice (2023) Vol. 245, pp. 154439-154439
Closed Access | Times Cited: 52
Treatment strategies for clear cell renal cell carcinoma: Past, present and future
Junwei Yang, Kuansong Wang, Zhichun Yang
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 46
Intra- and Peritumoral CT-Based Radiomics for Assessing Pathologic T-Staging in Clear Cell Renal Cell Carcinoma: A Multicenter Study
Yuanhao Xia, Zehua Sun, Zhongyi Wang, et al.
Annals of Surgical Oncology (2025)
Closed Access | Times Cited: 2
Risks from Deferring Treatment for Genitourinary Cancers: A Collaborative Review to Aid Triage and Management During the COVID-19 Pandemic
Christopher J.D. Wallis, Giacomo Novara, Laura Marandino, et al.
European Urology (2020) Vol. 78, Iss. 1, pp. 29-42
Open Access | Times Cited: 132
Noninvasive Fuhrman grading of clear cell renal cell carcinoma using computed tomography radiomic features and machine learning
Mostafa Nazari, Isaac Shiri, Ghasem Hajianfar, et al.
La radiologia medica (2020) Vol. 125, Iss. 8, pp. 754-762
Closed Access | Times Cited: 109
A Near-Infrared Peptide Probe with Tumor-Specific Excretion-Retarded Effect for Image-Guided Surgery of Renal Cell Carcinoma
Hong‐Wei An, Da‐Yong Hou, Rui Zheng, et al.
ACS Nano (2020) Vol. 14, Iss. 1, pp. 927-936
Closed Access | Times Cited: 102
Three‐dimensional virtual imaging of renal tumours: a new tool to improve the accuracy of nephrometry scores
Francesco Porpiglia, Daniele Amparore, Enrico Checcucci, et al.
BJU International (2019) Vol. 124, Iss. 6, pp. 945-954
Closed Access | Times Cited: 92
Predictive Value of Nephrometry Scores in Nephron-sparing Surgery: A Systematic Review and Meta-analysis
Alessandro Veccia, Alessandro Antonelli, Robert G. Uzzo, et al.
European Urology Focus (2019) Vol. 6, Iss. 3, pp. 490-504
Closed Access | Times Cited: 86
Prognostic and Predictive Value of PBRM1 in Clear Cell Renal Cell Carcinoma
Lucía Carril-Ajuria, María Santos, Juan María Roldán‐Romero, et al.
Cancers (2019) Vol. 12, Iss. 1, pp. 16-16
Open Access | Times Cited: 84
Single-Cell RNA Sequencing in Multiple Pathologic Types of Renal Cell Carcinoma Revealed Novel Potential Tumor-Specific Markers
Cheng Su, Yufang Lv, Wenhao Lu, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 80
Is off‐clamp robot‐assisted partial nephrectomy beneficial for renal function? Data from the CLOCK trial
Alessandro Antonelli, Luca Cindolo, Marco Sandri, et al.
BJU International (2021) Vol. 129, Iss. 2, pp. 217-224
Closed Access | Times Cited: 79
Robot-assisted Radical Nephrectomy: A Systematic Review and Meta-analysis of Comparative Studies
Fabio Crocerossa, Umberto Carbonara, Francesco Cantiello, et al.
European Urology (2020) Vol. 80, Iss. 4, pp. 428-439
Closed Access | Times Cited: 78
A Global Trend Analysis of Kidney Cancer Incidence and Mortality and Their Associations with Smoking, Alcohol Consumption, and Metabolic Syndrome
Junjie Huang, David Leung, Erica On-Ting Chan, et al.
European Urology Focus (2021) Vol. 8, Iss. 1, pp. 200-209
Closed Access | Times Cited: 77
Current evidence on screening for renal cancer
Juliet A. Usher‐Smith, Rebecca K. Simmons, Sabrina H. Rossi, et al.
Nature Reviews Urology (2020) Vol. 17, Iss. 11, pp. 637-642
Open Access | Times Cited: 73
Imaging Characterization of Renal Masses
Carlos Nicolau, Natalie Antunes, Blanca Paño, et al.
Medicina (2021) Vol. 57, Iss. 1, pp. 51-51
Open Access | Times Cited: 69
Collaborative Review: Factors Influencing Treatment Decisions for Patients with a Localized Solid Renal Mass
Thenappan Chandrasekar, Stephen A. Boorjian, Umberto Capitanio, et al.
European Urology (2021) Vol. 80, Iss. 5, pp. 575-588
Closed Access | Times Cited: 65
Three-dimensional Model–assisted Minimally Invasive Partial Nephrectomy: A Systematic Review with Meta-analysis of Comparative Studies
Federico Piramide, Karl‐Friedrich Kowalewski, Giovanni Cacciamani, et al.
European Urology Oncology (2022) Vol. 5, Iss. 6, pp. 640-650
Closed Access | Times Cited: 60
De Novo Malignancies after Kidney Transplantation
David P. Al‐Adra, Talal Al‐Qaoud, Kevin Fowler, et al.
Clinical Journal of the American Society of Nephrology (2021) Vol. 17, Iss. 3, pp. 434-443
Open Access | Times Cited: 59
Complementary roles of surgery and systemic treatment in clear cell renal cell carcinoma
Alexandre Ingels, Riccardo Campi, Umberto Capitanio, et al.
Nature Reviews Urology (2022) Vol. 19, Iss. 7, pp. 391-418
Closed Access | Times Cited: 46
Page 1 - Next Page

Scroll to top